Author

Jill L. Lee

Observed institutions: University of Minnesota, University of Minnesota Medical Center, University of Minnesota Children's Hospital

ORCID: 0009-0004-6965-0770

Observed ORCID: 0009-0004-6965-0770

OpenAlex ID: A5122190397

The Effect of Atorvastatin on Vascular Function and Structure in Young Adult Survivors of Childhood Cancer: A Randomized, Placebo-Controlled Pilot Clinical Trial

2017 · Kara L. Marlatt, Julia Steinberger, et al. · Journal of Adolescent and Young Adult Oncology · 15

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

2025 · Katherine A. Janeway, Alexander J. Chou, et al. · Clinical Cancer Research · 2

Data from A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

2026 · Katherine A. Janeway, Alexander J. Chou, et al.

Supplementary Material1 from A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

2026 · Katherine A. Janeway, Alexander J. Chou, et al.

Appendix1 from A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

2026 · Katherine A. Janeway, Alexander J. Chou, et al.

Works count: 5

Citation count: 17

H-index: 2

I10-index: 1